Cargando…
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
The neurofibromatosis type 2 (NF2) gene encodes merlin, a tumor suppressor protein frequently inactivated in schwannoma, meningioma, and malignant mesothelioma (MM). The sequence of merlin is similar to that of ezrin/radixin/moesin (ERM) proteins which crosslink actin with the plasma membrane, sugge...
Autores principales: | Sato, Tatsuhiro, Sekido, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979333/ https://www.ncbi.nlm.nih.gov/pubmed/29587439 http://dx.doi.org/10.3390/ijms19040988 |
Ejemplares similares
-
NF2 alteration in mesothelioma
por: Sekido, Yoshitaka, et al.
Publicado: (2023) -
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018) -
Role of Merlin/NF2 Inactivation in Tumor Biology
por: Petrilli, Alejandra M., et al.
Publicado: (2015) -
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
por: Kodama, Yuta, et al.
Publicado: (2021) -
The Role of Merlin/NF2 Loss in Meningioma Biology
por: Lee, Sungho, et al.
Publicado: (2019)